By Associate Professor David William Marshall Muller

Journal articles

Bhamra-Ariza P; Muller DWM, 2013, 'The MitraClip Experience and Future Percutaneous Mitral Valve Therapies', Heart Lung and Circulation, http://dx.doi.org/10.1016/j.hlc.2014.05.021

Muller DWM, 2012, 'Funding of new cardiac technologies in Australia', Medical Journal of Australia, 197, pp. 132 - 133, http://dx.doi.org/10.5694/mja12.10994

Jabbour A; Boshell D; Sesel K; Silverstone E; Muller DW; Stirrup J; Rubens M; Hayward CS; Wright S, 2012, 'Inducible myocardial ischaemic diagnosed using computed tomography dipyridamole stress myocardial perfusion technique', Journal of Medical Imaging and Radiation Oncology, 56, pp. 445 - 448, http://dx.doi.org/10.1111/j.1754-9485.2012.02363.x

Carotid Stenting Guidelines Committee: an Inter-collegiate Committee of the RACP (ANZAN, CSANZ), RACS (ANZSVS) and RANZCR , 2011, 'Guidelines for patient selection and performance of carotid artery stenting.', Intern Med J, 41, pp. 344 - 347, http://dx.doi.org/10.1111/j.1445-5994.2011.02445.x

Ormiston J; Meredith I; Walters D; Walton T; Pasupathi S; Muller D; Worthley S; Yong G; Whitbourn R, 2010, 'Early Effectiveness and Safety Results From the CoreValve Transcatheter Aortic Valve Australia-New Zealand Study', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 56, pp. B112 - B113, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209824200487&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Meredith IT; Worthley SG; Whitbourn R; Walters D; McClean D; Ormiston J; Horrigan M; Wilkins GT; Hendriks R; Matsis P; Muller D; Cutlip DE, 2010, 'Long-term clinical outcomes with the next-generation Resolute Stent System: A report of the two-year follow-up from the RESOLUTE clinical trial', EuroIntervention, 5, pp. 692 - 697, http://dx.doi.org/10.4244/EIJV5I6A114

Carotid Stenting Guidelines Committee ; Bladin C; Chambers B; New G; Denton M; Lawrence-Brown M, 2010, 'Guidelines for patient selection and performance of carotid artery stenting.', ANZ J Surg, 80, pp. 398 - 405, http://dx.doi.org/10.1111/j.1445-2197.2010.05330.x

Meredith IT; Ormiston J; Whitbourn R; Kay IP; Muller D; Cutlip DE, 2009, 'Five-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, first-in-human study', Catheterization and Cardiovascular Interventions, 74, pp. 989 - 995, http://dx.doi.org/10.1002/ccd.22206

Bladin C; Chambers B; New G; Denton M; Lawrence-Brown M; Levi C; David Muller D; Davis S; Donnan G; Crimmins D; Frayne J; Phatouros C; Scroop R; Harrington T, 2009, 'Guidelines for patient selection and performance of carotid artery stenting', Journal of Medical Imaging and Radiation Oncology, 53, pp. 538 - 545, http://dx.doi.org/10.1111/j.1754-9485.2009.02120.x

Kassam I; Henderson D; Keogh A; Macdonald P; Muller D; Hayward C, 2008, 'Results of Percutaneous intervention in patients with Transplant Coronary Artery Disease: A Retrospective Analysis', Heart, Lung and Circulation, 17, pp. S180 - S180, http://dx.doi.org/10.1016/j.hlc.2008.05.427

Kovacic JC; Macdonald PS; Feneley MP; Muller DW; Freund J; Dodds AJ; Milliken ST; Tao H; Itescu S; Moore JJ; Ma DD; Graham RM, 2008, 'Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD 133(+) cell infusion in patients with chronic refractory ischemic heart disease: The G-CSF in Angina patients with IHD to stimulate Neovascul', American Heart Journal, 156, pp. 954 - 963

Ruchin PE; Muller DWM; Faddy SC; Baron DW; Roy PR; Wilson SH, 2007, 'Long-Term Clinical Follow-up of Sirolimus-Eluting (CYPHER™) Coronary Stents in the Treatment of InStent Restenosis in an Unselected Population', Heart Lung and Circulation, 16, pp. 440 - 446, http://dx.doi.org/10.1016/j.hlc.2007.02.090

Meredith IT; Ormiston J; Whitbourn R; Kay IP; Muller D; Popma JJ; Cutlip DE; Fitzgerald PJ, 2007, 'Four-Year Clinical Follow-Up After Implantation of the Endeavor Zotarolimus-Eluting Stent: ENDEAVOR I, the First-in-Human Study', American Journal of Cardiology, 100, http://dx.doi.org/10.1016/j.amjcard.2007.08.023

Kovacic JC; Macdonald P; Feneley MP; Muller DW; Ma D; Tao H; Freund J; Milliken S; Dodds A; Moore J; Itescu S; Graham RM, 2007, 'Abstract 2669: The Use of Granulocyte-Colony Stimulating Factor in Angina Patients to Stimulate Neovascularization: the GAIN I study', Circulation, 116, http://dx.doi.org/10.1161/circ.116.suppl_16.ii_591-d

Bacik BM; Muller D; Corbisiero R, 2007, 'Adaptive bi-atrial pacing improves the maintenance of sinus rhythm', PACE - Pacing and Clinical Electrophysiology, 30, pp. 492 - 497, http://dx.doi.org/10.1111/j.1540-8159.2007.00698.x

Ruchin PE; Baron DW; Wilson SH; Boland J; Muller DWM; Roy PR, 2007, 'Long-Term Follow-up of Renal Artery Stenting in an Australian Population', Heart Lung and Circulation, 16, pp. 79 - 84, http://dx.doi.org/10.1016/j.hlc.2006.12.008

Dehmer GJ; Blankenship J; Wharton TP; Seth A; Morrison DA; DiMario C; Muller D; Kellett M; Uretsky BF, 2007, 'The current status and future direction of percutaneous coronary intervention without on-site surgical backup: An expert consensus document from the Society for Cardiovascular Angiography and Interventions', Catheterization and Cardiovascular Interventions, 69, pp. 471 - 478, http://dx.doi.org/10.1002/ccd.21097

Kovacic JC; Muller DW; Graham RM, 2007, 'Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease', Journal of Molecular and Cellular Cardiology, 42, pp. 19 - 33

Ruchin PE; Faddy S; Muller DW; Baron D; Roy PR; Wilson S, 2007, 'Clinical Follow-Up of Paclitaxel-Eluting (TAXUS) Sents for the Treatment of Saphenous Vein Graft Disease', Journal of Interventional Cardiology, 20 (4), pp. 258 - 264

Wright SP; Silverstone E; Baker L; Keary L; Holloway C; Easey N; Welsh N; Muller D, 2007, 'Diagnostic Accuracy of CT Coronary Angiography Compared with Invasive Coronary Angiography: Initial Experience At St Vincent's Hospital, Sydney', Heart, Lung and Circulation, 16, pp. S55 - S55, http://dx.doi.org/10.1016/j.hlc.2007.06.141

O'Loughlin AJC; Keogh A; Muller DWM, 2006, 'Insertion of a Fenestrated Amplatzer Atrial Septostomy Device for Severe Pulmonary Hypertension', Heart Lung and Circulation, 15, pp. 275 - 277, http://dx.doi.org/10.1016/j.hlc.2006.02.002

Kovacic JC; Roy PR; Baron D; Muller DW, 2006, 'Staged carotid artery stenting and coronary artery bypass graft surgery: Initial results from a single center', Catheterization and Cardiovascular Interventions, 67, pp. 142 - 148

Ma DDF; Kovacic JC; Dodds A; Tao H; McDonald P; Feneley MP; Muller DW; Fruend J; Milliken S; Moore J; Itescu S; Graham RM, 2005, 'Granulocyte-Colony Stimulating Factor Decreases Angina and Improves Exercise Capacity in Patients with Chronic Refractory ‘No Option’ Ischemic Heart Disease.', Blood, 106, pp. 4215 - 4215, http://dx.doi.org/10.1182/blood.v106.11.4215.4215

Muller D, 2005, 'First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial.', Eurointervention, 1, pp. 157 - 164

Kotlyar E; Keogh AM; Thavapalachandran S; Allada CS; Sharp J; Dias L; Muller D, 2005, 'Prehydration alone is sufficient to prevent contrast-induced nephropathy after day-only angiography procedures - A randomised controlled trial', Heart Lung and Circulation, 14, pp. 245 - 251, http://dx.doi.org/10.1016/j.hlc.2005.06.007

Ma DD; Kovacic JC; Dodds AJ; Tao H; Mcdonald PS; Feneley MP; Muller DW; Fruend J; Milliken ST; Moore JJ; Itescu S; Graham RM, 2005, 'Granulocyte-colony stimulating factor decreases angina and improves exercise capacity in patients with chronic refractory `no option` ischemic heart disease', Blood, 106, pp. 134B - 134B

Kovacic JC; Roy P; Baron D; Gunalingam B; Muller DW, 2005, 'Percutaneous carotid artery stenting: a strategy in evolution', Internal Medicine Journal, 35, pp. 143 - 150

Kovacic JC; Muller DW; Harvey RJ; Graham RM, 2005, 'Update on the use of stem cells for cardiac disease', Internal Medicine Journal, 35, pp. 348 - 356

Meredith I; Ormiston J; Whitbourn R; Kay P; Muller DW; Popma J; Fitzgerald PE; Kuntz R, 2004, 'ENDEAVOR I safety and efficacy study: 12-month results', American Journal of Cardiology, 94, pp. 68E - 68E, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224406500153&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Keogh AM; Muller DW; Faddy S; Ruygrok P; Richardson M; Galbraith A, 2004, 'Sirolimus provides protection from graft vasculopathy at 2 years afterheart transplantation', American Journal of Transplantation, 4, pp. 281 - 281, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000221322500447&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Meredith I; Ormiston J; Whitbourn R; Kay P; Muller DW; Popma J; Fitzgerald PA; Kuntz R, 2004, 'Endeavor I `first in human` safety and efficacy study - 12-month clinical, angiographic, and intravascular ultrasound results', Circulation, 110, pp. 563 - 564, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224783503077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Keogh A; Muller D; Faddy S; Ruygrok P; Richardson M; Galbraith A, 2004, 'HEART TRANSPLANT PATIENTS TREATED WITH SIROLIMUS IMMMUNOTHERAPY SHOW SIGNIFICANT REDUCTION IN THE PROGRESSION OF GRAFT VASCULOPATHY AT 2 YEARS', Transplantation, 78, pp. 160 - 160, http://dx.doi.org/10.1097/00007890-200407271-00421

Keogh A; Muller D; Faddy S; Ruygrok P; Richardson M; Galbraith A, 2004, 'Sirolimus from the time of heart transplantation - persistent protection from graft vasculopathy at 2 years', The Journal of Heart and Lung Transplantation, 23, pp. S106 - S107, http://dx.doi.org/10.1016/j.healun.2003.11.194

Keogh AM; Richardson M; Ruygrok P; Spratt P; Galbraith A; O Driscoll G; Macdonald PS; Esmore D; Muller DW; Faddy S, 2004, 'Sirolimus in de novo heart transplant recipients reduces acuterejection and prevents coronary artery disease at 2 years - Arandomized clinical trial', Circulation, 110, pp. 2694 - 2700

Kovacic JC; Muller DWM, 2003, 'Hypertrophic cardiomyopathy: State-of-the-art review, with focus on the management of outflow obstruction', Internal Medicine Journal, 33, pp. 521 - 529, http://dx.doi.org/10.1046/j.1445-5994.2003.00475.x

Ruygrok PN; Muller DW; Serruys PW, 2003, 'Rapamycin in cardiovascular medicine', Internal Medicine Journal, 33, pp. 103 - 109, http://dx.doi.org/10.1046/j.1445-5994.2003.00331.x

Ruygrok PN; Webber B; Faddy S; Muller DW; Keogh A, 2003, 'Angiographic regression of cardiac allograft vasculopathy after introducing sirolimus immunosuppression', Journal of Heart and Lung Transplantation, 22, pp. 1276 - 1279, http://dx.doi.org/10.1016/S1053-2498(02)01239-1

Connor DE; Joseph JE; Baron D; Muller DW; Roy P; Wilson S; Ma DD, 2003, 'Abciximab therapy post elective coronary artry stenting does not prevent a troponin rise mediated by increased levels of platelet P-selectin an dplatelet-monocyte aggregates', Journal of Thrombosis and Haemostasis, pp. 1769 - 1769

Freedman SB; Brieger D; Campbell TJ; Celermajer DS; Chalmers J; Feneley MP; Marwick TH; Muller DW; Tofler GH; Tonkin AM, 2002, 'Global cardiology and come to Australia: 14th world congress of cardiology, Sydney, 5-9 May 2002', Medical Journal of Australia, 177, pp. 473 - 475, http://dx.doi.org/10.5694/j.1326-5377.2002.tb04913.x

Safian RD; Feldman T; Muller DWM; Mason D; Schreiber T; Haik B; Mooney M; O'Neill WW, 2001, 'Coronary Angioplasty and Rotablator Atherectomy Trial (CARAT): Immediate and late results of a prospective multicenter randomized trial', Catheterization and Cardiovascular Interventions, 53, pp. 213 - 220, http://dx.doi.org/10.1002/ccd.1151

Simonini A; Moscucci M; Muller DWM; Bates ER; Pagani FD; Burdick MD; Strieter RM, 2000, 'IL-8 is an angiogenic factor in human coronary atherectomy tissue', Circulation, 101, pp. 1519 - 1526, http://dx.doi.org/10.1161/01.CIR.101.13.1519

Crowe JR; Shapo BM; Stephens DN; Bleam D; Eberle MJ; Céspedes EI; Wu CC; Muller DWM; Kovach JA; Lederman RJ; O’donnell M, 2000, 'Blood speed imaging with an intraluminal array', IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, 47, pp. 672 - 681, http://dx.doi.org/10.1109/58.842055

Hayes P; Muller D; Kuchar D, 2000, 'Left main coronary artery disease in a 40-year-old man receiving HIV protease inhibitors', Australian and New Zealand Journal of Medicine, 30, pp. 92 - 93, http://dx.doi.org/10.1111/j.1445-5994.2000.tb01066.x

Moscucci M; O'Connor GT; Ellis SG; Malenka DJ; Sievers J; Bates ER; Muller DWM; Werns SW; Rogers EK; Karavite D; Eagle KA, 1999, 'Validation of risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty mortality on an independent data set', Journal of the American College of Cardiology, 34, pp. 692 - 697, http://dx.doi.org/10.1016/S0735-1097(99)00266-1

Rabah M; Mason D; Muller DWM; Hundley R; Kugelmass AD; Weiner B; Cannon L; O'Neill WW; Safian RD, 1999, 'Heparin after percutaneous intervention (HAPI): A prospective multicenter randomized trial of three heparin regimens after successful coronary intervention', Journal of the American College of Cardiology, 34, pp. 461 - 467, http://dx.doi.org/10.1016/S0735-1097(99)00195-3

Moscucci M; Ricciardi M; Eagle KA; Kline E; Bates ER; Werns SW; Karavite D; Muller DWM, 1998, 'Frequency, predictors, and appropriateness of blood transfusion after percutaneous coronary interventions', American Journal of Cardiology, 81, pp. 702 - 707, http://dx.doi.org/10.1016/S0002-9149(97)01018-7

Punamiya K; Bates ER; Shea MJ; Muller DWM, 1997, 'Endoluminal stenting for unprotected left main stenosis in Takayasu's arteritis', Catheterization and Cardiovascular Diagnosis, 40, pp. 272 - 275, http://dx.doi.org/10.1002/(SICI)1097-0304(199703)40:3<272::AID-CCD11>3.0.CO;2-R

Labhasetwar V; Chen B; Muller DWM; Bonadio J; Ciftci K; March K; Levy RJ, 1997, 'Gene-based therapies for restenosis', Advanced Drug Delivery Reviews, 24, pp. 109 - 120, http://dx.doi.org/10.1016/S0169-409X(96)00485-1

Muller DWM, 1997, 'The role of proto-oncogenes in coronary restenosis', Progress in Cardiovascular Diseases, 40, pp. 117 - 128, http://dx.doi.org/10.1016/S0033-0620(97)80004-7

Punamiya K; Beekman RH; Shim D; Muller DWM, 1996, 'Percutaneous transhepatic mitral commissurotomy', Catheterization and Cardiovascular Diagnosis, 39, pp. 204 - 206, http://dx.doi.org/10.1002/(SICI)1097-0304(199610)39:2<204::AID-CCD22>3.0.CO;2-F

Back to profile page